Arash Mostaghimi, MD, MPA, MPH: Pearls in Dermatopathology and Alopecia
Arash Mostaghimi, MD, MPA, MPH, provides a comprehensive overview of his SDPA conference sessions, "Understanding the Pathology Report and Basic Biopsies," "Beyond the H&E," and "Alopecia: Treating Challenging Cases."
Dupilumab Improved Itch and Pain in Adults With Prurigo Nodularis
The drug also demonstrated efficacy in improving sleep quality and reducing sleep disruption.
Creating Goals Ahead of Psoriasis Action Month
Melodie Young, MSN, ANP-c, shares pearls on why prioritizing skin checks during Psoriasis Action Month in August is critical.
SDPA Annual Summer Dermatology Conference Recap: Day 3
Catch up on coverage from the third day of the 2023 SDPA Annual Summer Dermatology Conference.
Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD
Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCE
Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Recognizing and Treating Hidradenitis Suppurativa With Joslyn Kirby, MD
Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.
Abrocitinib Did Not Impact Immune Responses to Vaccination in Adolescents With Atopic Dermatitis
A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.
Conservative Imputation Method Efficacious in Moderate-to-Severe Hidradenitis Suppurativa
With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.
Survey Shows Building Rapport With Patients May Result in Better Treatment Outcomes
The National Psoriasis Foundation found that patients were frustrated by a lack of treatment options.
Effects of Spesolimab on Hidradenitis Suppurativa Lesions Leads to Additional Research
In a Maui Derm NP+PA Summer poster presentation, investigators revealed that treatment with spesolimab resulted in a reduction of lesions.
SDPA Annual Summer Dermatology Conference Recap: Day 2
Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.
Dupilumab Efficacious in Urticaria Symptom, Quality of Life Improvement
Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.
Renata Block, MMS, PA-C, Discusses the Role of the Dermatology PA Foundation in Supporting Physician Assistants
Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.
Tapinarof Demonstrates Efficacy in Patient With Nonulcerated Necrobiosis Lipoidica
In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.
John Barbieri, MD, MBA, FAAD: Aligning Treatments With Patients' Experiences
John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"
Skin Cancer in the Realm of Inflammatory Dermatoses
Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.
Rising Antifungal Resistance Poses a Threat to Onychomycosis Treatment
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.
Reviewing Considerations for Pigmentary Disorders With Nicole Gunasekera, MD, MBA
Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.
Survey Results Show Moderate to Severe Psoriasis Increases Anxiety and Depression Levels
Researchers evaluated factors affecting quality of life and what to consider when determining a patient’s psoriasis treatment plan.
2 Clarke Drive Cranbury, NJ 08512